These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3108979)

  • 1. Purification of three fragments of the dermonecrotic toxin from Pasteurella multocida.
    Nakai T; Kume K
    Res Vet Sci; 1987 Mar; 42(2):232-7. PubMed ID: 3108979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation and certain properties of the dermonecrotic toxin from Pasteurella multocida].
    Kalmykova LI; Ezepchuk IuV; Shegidevich EA; Navasardiants DG
    Mol Gen Mikrobiol Virusol; 1991 Aug; (8):29-32. PubMed ID: 1784303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of dermonecrotic toxin prepared from sonic extracts Bordetella bronchiseptica.
    Kume K; Nakai T; Samejima Y; Sugimoto C
    Infect Immun; 1986 May; 52(2):370-7. PubMed ID: 3699886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Pasteurella strains producing a toxin similar to the dermonecrotic toxin of Pasteurella multocida subspecies multocida.
    Kamp EM; ter Laak EA; de Jong MF
    Vet Rec; 1990 Apr; 126(17):434-7. PubMed ID: 2111955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and purification of two antigenically active, "complimentary" polypeptide fragments of tetanus neurotoxin.
    Matsuda M; Yoneda M
    Infect Immun; 1975 Nov; 12(5):1147-53. PubMed ID: 1104484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of dermonecrotic toxin from a sonic extract of Pasteurella multocida SP-72 serotype D.
    Nakai T; Sawata A; Tsuji M; Samejima Y; Kume K
    Infect Immun; 1984 Nov; 46(2):429-34. PubMed ID: 6542070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of a heat labile dermonecrotic toxin from culture fluid of Pasteurella multocida.
    Kamp EM; Van der Heijden PJ; Tetenburg BJ
    Vet Microbiol; 1987 Mar; 13(3):235-48. PubMed ID: 3660579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of pneumonia in rabbits by use of a purified protein toxin from Pasteurella multocida.
    Chrisp CE; Foged NT
    Am J Vet Res; 1991 Jan; 52(1):56-61. PubMed ID: 1826990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial purification of an osteolytic toxin from Pasteurella multocida.
    Chanter N; Rutter JM; Mackenzie A
    J Gen Microbiol; 1986 Apr; 132(4):1089-97. PubMed ID: 3760819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pasteurella multocida isolated from rabbits and swine: serologic types and toxin production.
    Rimler RB; Brogden KA
    Am J Vet Res; 1986 Apr; 47(4):730-7. PubMed ID: 3963576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of nasal turbinate atrophy in germ-free pigs, using Pasteurella multocida as well as bacterium-free crude and purified dermonecrotic toxin of P multocida.
    Kamp EM; Kimman TG
    Am J Vet Res; 1988 Nov; 49(11):1844-9. PubMed ID: 3247905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of dermonecrotic toxin produced by serotype D strains of Pasteurella multocida.
    Nakai T; Sawata A; Tsuji M; Kume K
    Am J Vet Res; 1984 Nov; 45(11):2410-3. PubMed ID: 6441488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of the toxin gene from Pasteurella multocida and its role in atrophic rhinitis.
    Lax AJ; Chanter N
    J Gen Microbiol; 1990 Jan; 136(1):81-7. PubMed ID: 2351955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
    Izumi N; Kondo H; Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of Bordetella bronchiseptica dermonecrotic toxin.
    Horiguchi Y; Nakai T; Kume K
    Microb Pathog; 1989 May; 6(5):361-8. PubMed ID: 2770506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, purification, and characterization of fragment B, the NH2-terminal half of the heavy chain of tetanus toxin.
    Matsuda M; Lei DL; Sugimoto N; Ozutsumi K; Okabe T
    Infect Immun; 1989 Nov; 57(11):3588-93. PubMed ID: 2478476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Miyazaki S; Sakaguchi G
    Infect Immun; 1977 Dec; 18(3):761-6. PubMed ID: 412790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Purification and characterization of erythrogenic toxins. I. Investigation of erythrogenic toxin A produced by Streptococcus pyogenes strain NY-5 (author's transl)].
    Gerlach D; Knöll H; Köhler W
    Zentralbl Bakteriol A; 1980; 247(2):177-91. PubMed ID: 6775448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of dermonecrotic toxin genes in Pasteurella multocida strains using the polymerase chain reaction (PCR)].
    Hotzel H; Erler W; Schimmel D
    Berl Munch Tierarztl Wochenschr; 1997 Apr; 110(4):139-42. PubMed ID: 9182513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Purification and characteristics of a protective factor from Bacillus anthracis toxin].
    Abalakin VA; Sergeeva LV; Cherkasova TD
    Biokhimiia; 1988 Feb; 53(2):283-8. PubMed ID: 3130898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.